The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hyperprogressive disease in patients with recurrent high grade gliomas treated with immune checkpoint inhibitors or other therapies.
 
Laura Donovan
No Relationships to Disclose
 
Samuel Gedailovich
No Relationships to Disclose
 
Adela Joanta-Gomez
No Relationships to Disclose
 
Jessica Schulte
No Relationships to Disclose
 
Teri Nguyen Kreisl
No Relationships to Disclose
 
Andrew B. Lassman
Honoraria - Abbvie; WebMD
Consulting or Advisory Role - Abbvie; Agios; BioClinica; Celgene; Cortice; Kadmon; Karyopharm Therapeutics; Northwest Biotherapeutics; Orbus Therapeutics; Sapience Therapeutics
Research Funding - Abbvie (Inst); Aeterna Zentaris (Inst); Amgen (Inst); BeiGene (Inst); Celldex (Inst); Genentech/Roche (Inst); Kadmon (Inst); Karyopharm Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Oncoceutics (Inst); Pfizer (Inst); VBI Vaccines (Inst)
Travel, Accommodations, Expenses - Agios; Karyopharm Therapeutics; Novocure
 
Mary Roberta Welch
Research Funding - Boston Biomedical; Inovio Pharmaceuticals
Travel, Accommodations, Expenses - Boston Biomedical; Inovio Pharmaceuticals
 
Aya Haggiagi
No Relationships to Disclose
 
Fabio Massaiti Iwamoto
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck; Novocure; Regeneron
Speakers' Bureau - Prime Oncology